Pharmaceuticals Market Research Reports & Industry Analysis

... report from VPGMarketResearch.com provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 France Drugs of Abuse Testing Market: Hospitals and Commercial Labs” is a unique study designed ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Germany Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices” is a unique study ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... , such as specimen preparation devices, controls, calibrators and others. “2015-2019 Germany Therapeutic Drug Monitoring (TDM) Market in Germany: Hospitals, Commercial Labs, Physician Offices” is a unique market and ...

... VPGMarketResearch.com contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Global Drugs of Abuse Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan ...

... VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Global Therapeutic Drug Monitoring (TDM) Market: US, Europe (France, Germany, Italy, Spain, UK), Japan ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Italy Drugs of Abuse Testing Market: Hospitals and Commercial Labs” is a unique study designed ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Italy Therapeutic Drug Monitoring (TDM) Market: Hospitals and Commercial Labs” is a unique market and ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Japan Drugs of Abuse Testing Market: Hospitals and Commercial Labs” is a unique study designed ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... , such as specimen preparation devices, controls, calibrators and others. “2015-2019 Japan Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs” is a unique market and technology ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Spain Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 Spain Therapeutic Drug Monitoring (TDM) Market: Hospitals, Commercial Labs, Ambulatory Care Centers” is a unique ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 UK Drugs of Abuse Testing Market: Hospitals and Commercial Labs” is a unique study designed ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 UK Therapeutic Drug Monitoring (TDM) Market: Hospitals and Commercial Labs” is a unique market and ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 US Drugs of Abuse Testing Market: Hospitals, Commercial Labs, Physician Offices” is a unique study ...

... -page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... products, such as specimen preparation devices, controls, calibrators and others. “2015-2019 US Therapeutic Drug Monitoring (TDM) Market: Hospitals, Commercial Labs, Physician Offices” is a unique market ...

During the next decade, the abused drug testing market will undergo significant transformation. These changes will be ... products, such as specimen preparation devices, controls, calibrators and others. Drugs of Abuse Testing Market: US, Europe, Japan is a unique study designed to help current ...

... products, such as specimen preparation devices, controls, calibrators and others. Therapeutic Dry Monitoring: US, Europe, Japan is a unique worldwide market and technology assessment ...

... accounted for over XXX% share of the global Alzheimer’s disease drugs market in 2014. iGATE RESEARCH report titled “Global Alzheimer’s Disease Drugs Market & Pipeline Drugs Market Analysis to 2020” is a 150 page report with 74 Figures and 10 Tables. This report analyses the Alzheimer’s Disease Drugs Market, Alzheimer’s Disease Pipeline Drugs Market and Clinical ...

... China while other companies like Shandong Wanjie High-tech Co., Ltd, Yangtze River Pharmaceutical Group and Disha Pharmaceutical Group shared the rest market share. The annual sales value of glipizide ...

... Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd took up a market share of about 97% for sales value in China while other companies like TIPR Pharmaceutical Responsible Co., Ltd, Jiangsu Vanguard Pharmaceutical Co., Ltd and Jilin Jinheng Pharmaceutical Co., Ltd and Shijiazhuang Yiling Pharmaceutical ...

... cancer and kidney cancer in China grows gradually. According to the Guidelines for Kidney Cancer Diagnosis and Treatment in China (the 2013 version), kidney cancer accounts for 2%-3% of adult malignant tumors in China ...

... after order is placed. Anti-diabetic pharmaceuticals market in India is considered to be one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world, after ...

... analgesia. Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to ... trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world. Parecoxib develops fast after entering China in 2008. ...

... Boehringer Ingelheim (Spain), Shenya Xin Ma Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceuticals Co., Ltd and Boehringer Ingelheim (Shanghai) occupy the majority of the Chinese market, among which Boehringer Ingelheim ...

... Merck Serono (rhFSH?), Livzon Pharmaceutical Group Co., Ltd (UFSH), IBSA (UFSH) and Organon (rhFSH?) dominate the Chinese market, among which Livzon Pharmaceutical Group Co., Ltd ...

... China in 1996. Pfizer, Inc., Zhejiang Jingxin Pharmaceutical Co., Ltd, Tianjin Huajin Pharmaceutical Factory, Guangdong P.D. Pharmaceutical Co., Ltd and Chengdu Leer Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Pfizer ...

... Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd ...

... JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory, Chuang Li Yao Ye, Kanion Pharmaceutical, Nanjing Luye Sike Pharma Co., Ltd and Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory ...

... GlaxoSmithKline (Tianjin) Co., Ltd, United Laboratories, Fujian Cosunter Pharmaceutical Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline (Tianjin) Co., Ltd ...

... GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited ...

... Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd ...

... of RNAII for injection made by different enterprises in China market outlook of RNAII for injection in China The author suggests the following groups of people purchase this report: manufacturers of immunomodulator investors ...

... Sino-American Shanghai Squibb occupy about 80% of the metformin market in China while the rest market share is taken up by such companies as Liling and Hebei Ideal & Hightech Pharmaceutical Co., Ltd. Apart from diabetes, metformin ...

... repaglinide of Novo Nordisk A/S came to be sold in China ... Hanson Pharmaceutical only occupies less than 11% of the market. The sales value of repaglinide ...

... Beijing Novartis Pharma Ltd. took up a market share of about 95% for sales value in 2014 while other companies like Deyuan Pharm, Luoxin Pharmacy Group Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd together occupied about 5% of the nateglinide market in China ...

... Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd took up a market share of about 86% for sales value and Sanofi occupied nearly 90% of the glimepiride market in China if Aventis (Italy ...

... Servier (France) and its subsidiary Servier (Tianjin) Pharmaceutical Co., Ltd took up a market share of about 96% for sales value in China while other companies like Tianjin Huajin Pharmaceutical Co., Ltd, Helioeast and Beijing Wansheng Pharmaceutical Co., Ltd ...

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market ...

... Antibody Drug Conjugates (ADCs) in pipeline highlight the potential for new therapeutic innovations in the ADC industry. According to this edition of the report “Global Antibody Drug Conjugate Market Outlook 2020”, the ADC market is anticipated to reach around US$ 12.7 Billion by 2020. In our report, there is a detailed analysis of the market for ADCETRIS ...

... Breast Cancer Incidence & Prevalence US Breast Cancer Therapy Market Overview US Breast Cancer Drug Clinical Pipeline by Company & Phase US Breast Cancer Drug Clinical Pipeline: 251 Drugs Majority Drugs in Phase-II Trials: 73 Drugs Marketed Breast Cancer Drugs in US: 32 Drugs Breast Cancer ...

... , the global erythropoietin market is expected to scale newer heights. The latest research by RNCOS titled “Global Erythropoietin Market Outlook 2020”, unfolds the market dynamics of the erythropoietin market. In this report, the global erythropoietin industry ... global market. Our industry analysts studied all the facets of the global erythropoietin market to portray a crystal-clear picture of the current as well as the expected future market outlook ...

... entitled “Global Microfluids Market Outlook 2020”, describes the overall microfluidics industry landscape with core emphasis on healthcare applications. According to analysis, the market for healthcare microfluidic devices was worth US$2.5 Billion in 2014 and is poised for a double digit growth during the forecasted period (2014-2020 ...

... titled “Global Vitamin and Supplements Market: Trends and Opportunities (2015-2019)” provides an insight into the vitamin and vitamin supplements market world-wide with focus on present market size and growth expected in the near future. The report analyzes the key vitamins – Vitamin B, Vitamin C, Vitamin ...

... & Prevalence Blood Cancer Drug Market Overview Blood Cancer Drug Market Dynamics Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline Insight Leukemia, Lymphoma & Myeloma Drug Clinical Pipeline: 435 Drugs Majority Drugs in Phase-I Clinical Trials: 128 Drugs Marketed Leukemia, Lymphoma & Myeloma Drug Clinical ...

... to deliver an experience patients will remember. Getting apps right is critical if Pharma is to successfully transform itself into a truly patient-centered business. Patient-centric Mobile Apps: Key Opportunities and Challenges for Pharma gives you the information you need to understand what patients, healthcare providers ...

... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive ...

... from VPGMarketResearch contains 14 tables, and provides a comprehensive analysis of thePOC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements ... sales forecasts for drugs of abuse procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Ambulatory Care Centers- Analysis of drugs of abuse procedures Competitive ...

... identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The ... business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading ...

... , including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also ...

This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating molecular diagnostics methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e. g. , DNA ...